Publications by authors named "Vikash Reebye"

Claim this Profile
R
RNA activation of improves leukemia treatment.
Olivia Kovecses, Bahram Sharif-Askari, Cristobal Gonzalez-Losada, Vikash Reebye, Bríd M Ryan

Mol Ther Nucleic Acids· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: RNA activation of improves leukemia treatment.
Olivia Kovecses, Bahram Sharif-Askari, Cristobal Gonzalez-Losada, Vikash Reebye, Bríd M Ryan

Mol Ther Nucleic Acids· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TIMEPOINT, a phase 1 study combining MTL-CEBPA with pembrolizumab, supports the immunomodulatory effect of MTL-CEBPA in solid tumors.
Ruth Plummer, Mikael H Sodergren, Rose Hodgson, Bríd M Ryan, Nina Raulf, Vikash Reebye

Cell Rep Med· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effect of Interleukin-10 Immunotherapy on Renal Ischemia-Reperfusion Injury: A Systematic Review and Meta-Analysis of Preclinical Studies.
Apostolos Prionas, Karim Hamaoui, Konstantinos Vanezis, Vikash Reebye, Nagy Habib

Int J Mol Sci· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cannabidiol's cytotoxicity in pancreatic cancer is induced via an upregulation of ceramide synthase 1 and ER stress.
Nagina Mangal, Vikash Reebye, Nagy Habib, Mikael H Sodergren

J Cannabis Res· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing SIRT1 Gene Expression Using Small Activating RNAs: A Novel Approach for Reversing Metabolic Syndrome.
Pinelopi Andrikakou, Vikash Reebye, Daniel Vasconcelos, Sorah Yoon, Jon Voutila

Nucleic Acid Ther· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upregulation of C/EBPα Inhibits Suppressive Activity of Myeloid Cells and Potentiates Antitumor Response in Mice and Patients with Cancer.
Ayumi Hashimoto, Debashis Sarker, Vikash Reebye, Sheba Jarvis, Mikael H Sodergren

Clin Cancer Res· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cannabinoids in the landscape of cancer.
Nagina Mangal, Simon Erridge, Nagy Habib, Anguraj Sadanandam, Vikash Reebye

J Cancer Res Clin Oncol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MTL-CEBPA Combined with Immunotherapy or RFA Enhances Immunological Anti-Tumor Response in Preclinical Models.
Kai-Wen Huang, Choon Ping Tan, Vikash Reebye, Cheng Ean Chee, Dimitris Zacharoulis

Int J Mol Sci· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-α, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I Trial.
Debashis Sarker, Ruth Plummer, Tim Meyer, Mikael H Sodergren, Bristi Basu, Vikash Reebye

Clin Cancer Res· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver Activation of Hepatocellular Nuclear Factor-4α by Small Activating RNA Rescues Dyslipidemia and Improves Metabolic Profile.
Kai-Wen Huang, Vikash Reebye, Katherine Czysz, Simona Ciriello, Stephanie Dorman

Mol Ther Nucleic Acids· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted Delivery of C/EBPα-saRNA by RNA Aptamers Shows Anti-tumor Effects in a Mouse Model of Advanced PDAC.
Sorah Yoon, Kai-Wen Huang, Pinelopi Andrikakou, Daniel Vasconcelos, Piotr Swiderski, Vikash Reebye

Mol Ther Nucleic Acids· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms involved in the activation of C/EBPα by small activating RNA in hepatocellular carcinoma.
Xiaoyang Zhao, Vikash Reebye, Paul Hitchen, Jia Fan, Hongchi Jiang

Oncogene· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-inflammatory Activity of MTL-CEBPA, a Small Activating RNA Drug, in LPS-Stimulated Monocytes and Humanized Mice.
Jiehua Zhou, Haitang Li, Xin Xia, Alberto Herrera, Nicolette Pollock, Vikash Reebye

Mol Ther· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of Liver Cancer by C/EBPA saRNA.
Xiaoyang Zhao, Jon Voutila, Stephanos Ghobrial, Nagy A Habib, Vikash Reebye

Adv Exp Med Biol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene activation of CEBPA using saRNA: preclinical studies of the first in human saRNA drug candidate for liver cancer.
Vikash Reebye, Kai-Wen Huang, Vivian Lin, Sheba Jarvis, Pedro Cutilas

Oncogene· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Mechanism of Small Activating RNA Targeting CEBPA, a Novel Therapeutic in Clinical Trials for Liver Cancer.
Jon Voutila, Vikash Reebye, Thomas C Roberts, Pantelitsa Protopapa, Pinelopi Andrikakou

Mol Ther· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aptamer-Drug Conjugates of Active Metabolites of Nucleoside Analogs and Cytotoxic Agents Inhibit Pancreatic Tumor Cell Growth.
Sorah Yoon, Kai-Wen Huang, Vikash Reebye, Duncan Spalding, Teresa M Przytycka

Mol Ther Nucleic Acids· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted Delivery of C/EBPα -saRNA by Pancreatic Ductal Adenocarcinoma-specific RNA Aptamers Inhibits Tumor Growth In Vivo.
Sorah Yoon, Kai-Wen Huang, Vikash Reebye, Paul Mintz, Yu-Wen Tien

Mol Ther· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel RNA oligonucleotide improves liver function and inhibits liver carcinogenesis in vivo.
Vikash Reebye, Pål Sætrom, Paul J Mintz, Kai-Wen Huang, Piotr Swiderski

Hepatology· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploiting human CD34+ stem cell-conditioned medium for tissue repair.
Paul J Mintz, Kai-Wen Huang, Vikash Reebye, Georgios Nteliopoulos, Hong-Shiee Lai

Mol Ther· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Short-activating RNA Oligonucleotide Targeting the Islet β-cell Transcriptional Factor MafA in CD34(+) Cells.
Vikash Reebye, Pål Sætrom, Paul J Mintz, John J Rossi, Noriyuki Kasahara

Mol Ther Nucleic Acids· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of the HSP90-associated cochaperone p23 in enhancing activity of the androgen receptor and significance for prostate cancer.
Vikash Reebye, Laia Querol Cano, Derek N Lavery, Greg N Brooke, Sue M Powell

Mol Endocrinol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNA-181a* Targets Nanog in a Subpopulation of CD34(+) Cells Isolated From Peripheral Blood.
Paul J Mintz, Pål Sætrom, Vikash Reebye, Marie B Lundbæk, Kaiqin Lao

Mol Ther Nucleic Acids· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis